March 23, 2011 | Filed under: Health,News | Posted by:
Patients with a specific subtype of Duchenne’s muscular dystrophy have improved muscle function after 12 weeks of treatment with experimental drug PRO051, an early clinical study finds.
Posted by
on March 23, 2011. Filed under Health, News.
You can follow any responses to this entry through the RSS 2.0.
You can skip to the end and leave a response. Pinging is currently not allowed.
Posted by
on March 23, 2011. Filed under